Identification of Barrett’s esophagus patients at higher risk for adenocarcinoma development

100 %
0 %
Information about Identification of Barrett’s esophagus patients at higher risk for...

Published on August 4, 2007

Author: ikovic

Source: slideshare.net

Description

Final presentation given by Ileana Lulic and Ivor Kovic at the end of Scientific research in gastro-intestinal & liver diseases
Sunday, July 8 - Friday, August 3, 2007
Amsterdam, Academisch Medisch Centrum

Identification of Barrett’s esophagus patients at higher risk for adenocarcinoma development Ileana Lulic, Ivor Kovic

Definition “... a change in the esophageal epithelium of any length that can be recognized at endoscopy and is confirmed to have intestinal metaplasia by biopsy ...” American College of Gastroenterology

Characteristics • Caucasian males – middle age • Rapidly rising incidence in Western countries • Around 150x higher risk of esophageal adenocarcinoma compared to general population • 0.5% of BE patients will develop EAC • Overall survival rate of EAC = 20-25%

Progression Squamous esophageal epithelium Intestinal metaplasia Dysplasia Esophageal adenocarcinoma

Progression Squamous esophageal epithelium GERD Intestinal metaplasia Dysplasia Esophageal adenocarcinoma

Progression Squamous esophageal epithelium Obesity Diet ? GERD Tobacco Alcohol Bacteria Intestinal metaplasia Dysplasia Esophageal adenocarcinoma

Progression Squamous esophageal epithelium Obesity Diet ? GERD Tobacco Alcohol Bacteria Intestinal metaplasia Dysplasia Low grade High grade Esophageal adenocarcinoma

Diagnosis Normal Metaplasia Adenocarcinoma Endoscopy Pathology

Diagnosis Normal Metaplasia Adenocarcinoma Endoscopy Pathology http://www.gastrointestinalatlas.com/

Diagnosis Normal Metaplasia Adenocarcinoma Endoscopy Pathology

Surveillance problems Endoscopy Pathology • • Intra-observer variability Difficulty of identifying early neoplastic lesions • Inter-observer variability • Sampling errors • Expensive and time consuming

Surveillance problems Endoscopy Pathology • • Intra-observer variability Difficulty of identifying early neoplastic lesions • Inter-observer variability • Sampling errors • Expensive and time consuming Questionable cost-effectiveness

Potential of genetic markers • Prediction of risk for disease progression in endoscopic surveillance program • Early detection of high grade dysplasia and invasive adenocarcinoma • Staging and prognosis • Prediction of chemosensitivity • Novel targets for anticancer therapies

Genetic markers p16/9p-loss p53/17p-loss Y chromosome loss Aneuploidy/tetraploidy Losses - 3p, 4p, 7q, 12q,17q Gains – 2p, 8q, 20q

Genetic markers p16/9p-loss No dysplasia p53/17p-loss Low grade dysplasia Y chromosome loss Aneuploidy/tetraploidy High grade dysplasia Losses - 3p, 4p, 7q, 12q,17q Esophageal adenocarcinoma Gains – 2p, 8q, 20q

Genetic markers p16/9p-loss p53/17p-loss Y chromosome loss Aneuploidy/tetraploidy Losses - 3p, 4p, 7q, 12q,17q Gains – 2p, 8q, 20q

Genetic markers p16/9p-loss Fluorescent in situ hybridization p53/17p-loss Y chromosome loss Image cytometry Aneuploidy/tetraploidy Losses - 3p, 4p, 7q, 12q,17q Gains – 2p, 8q, 20q

Procedure Image cytometry Brush cytology Slides preparation FISH

FISH • Fluorescent probe • Fluorescent microscopy

FISH • Numerical chromosomal changes: aneuploidy • Locus specific losses: tumor suppressor genes • Amplifications: oncogenes and growth factor

Image cytometry • DNA ploidy analysis • Aneuploidy – from 2N to 4N, DNA index • Measurement of optical density

FISH results Cep1 p16 p53 Patient Hystology loss gain loss gain loss gain + + 1 LGD + 2 LGD + + + 3 HGD + + 4 HGD + + + 5 HGD + + 6 HGD Total 2 3 5 0 3 0

Image cytometry results

Image cytometry results

Results LGD HGD 6 5 4 3 2 1 0 Cep 1 gain p16 loss p53 loss

Results from 151 patients (n=114) (n=24) (n=13)

Conclusion • p53 loss and aneuploidy are promising markers for dysplasia development in BE • Ongoing follow up study to demonstrate the true predictive value of these markers

Agnieszka Rygiel Francesca Milano Sheila Krishnadath Wendy Bruins Willemijn van Dop

Add a comment

Related presentations

Related pages

Identification of Barrett’s esophagus patients at higher ...

×Close Share Identification of Barrett’s esophagus patients at higher risk for adenocarcinoma development
Read more

Barrett's esophagus and cancer risk: how research advances ...

Barrett's esophagus and cancer risk: ... is the only known precursor to esophageal adenocarcinoma ... The identification of patients at a higher risk of ...
Read more

Barrett's adenocarcinoma : GI Motility online - Nature

Barrett's adenocarcinoma. ... It also allows identification of patients with advanced disease unlikely to ... Barrett's esophagus and risk of esophageal ...
Read more

Adenocarcinoma of the Esophagus: Risk Factors and ...

Adenocarcinoma of the Esophagus: Risk Factors ... cancer risk in patients with Barrett s esophagus ... have a higher risk for developing adenocarcinoma of ...
Read more

How should patients with Barrett’s esophagus be monitored?

How should patients with Barrett’s esophagus be ... allow identification of higher risk Barrett’s ... malignant lesion for adenocarcinoma of the esophagus.
Read more

Barrett’s Esophagus - American Family Physician

Identification of patients at risk for ... stricture or the development of Barrett’s esophagus. ... of Barrett’s esophagus is much higher in ...
Read more

Persistence of Nondysplastic Barrett's Esophagus ...

... patients who are at low risk for development ... patients had a higher or lower risk than ... nondysplastic Barrett's esophagus have ...
Read more

Endoscopic Ultrasound in Barrett's Esophagus

Endoscopic Ultrasound in Barrett's Esophagus ... Patients with Barrett's esophagus have a 30 to 125 times higher risk of developing adenocarcinoma ...
Read more

Barrett's Esophagus: Can Biomarkers Predict Progression to ...

Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress to esophageal adenocarcinoma. It is characterized histologically ...
Read more